Syndax

Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.

Founded

2005

Raised

$40.5M

Follow us

Companies in the same industry

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2019
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Add info

Latest funding Show all

$4,947,480

Debt financing - 2014

$26,600,000

Venture capital (Series B) - 2013

Domain Associates MPM Capital RusnanoMedInvest +1

Team Size

50+

Employees

Health Stock markets